Skip to content
MedsAcross

Medicine

Testosterone 1.62% gel

Testosterone · Transdermal
Available on requestPrescription onlyUS FDAControlled, schedule CIIIGeneric name

Testosterone 1.62% gel is a generic prescription medicine for transdermal use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at controlled room temperature 20° to 25°C (68° to 77°F), excursions…

Key facts

Active ingredient (INN)
Testosterone
Brand
Sold under the generic name
Strength
1.62%
Dosage form
Gel
Route
Transdermal
Packs
1 bottle, 30 packets and 9 more
Manufacturers
Alembic PharmaceuticalsIndiaLupinIndiaActavis PharmaBryant Ranch PrepackEncube EthicalsPrasco LaboratoriesNorthStar RxXiromed9 labelers on the register
Origin register
US FDA, United States
Storage
Store at controlled room temperature 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIII
ATC code
G03BA03 Testosterone
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
10 April 2019
Identifiers
RxCUI 1597076, 1597126, 1597120DailyMed set ID 65981b8a-d5cc-1964-7eac-a07f032c2571, 6c7d2dec-6492-4d53-b110-61ffeae9ee61, 44a04f66-fd2a-45c7-934e-8f14c023ce14 +7NDC 72603-265, 63629-2352, 21922-030 +9Application ANDA210835, ANDA208620, ANDA209390 +4

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump62332-552-88Alembic PharmaceuticalsIndia4 March 2021
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump68180-941-11LupinIndia10 April 2019
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump0591-2924-18Actavis Pharma10 April 2019
30 packet in 1 carton / 2.5 g in 1 packet0591-2926-30Actavis Pharma12 February 2021
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump21922-030-20Encube Ethicals5 June 2024
30 packet in 1 carton / 2.5 g in 1 packet21922-030-52Encube Ethicals1 June 2026
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump70700-112-21Xiromed8 May 2020
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump63629-2352-1Bryant Ranch Prepack8 May 2020
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump72162-1962-2Bryant Ranch Prepack7 February 2024
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump66993-951-88Prasco Laboratories19 May 2025
30 packet in 1 carton / 2.5 g in 1 packet66993-952-30Prasco Laboratories1 December 2025
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump72603-265-01Northstar Rx24 January 2024
30 packet in 1 carton / 1.25 g in 1 packet45802-281-39—27 June 2019
30 packet in 1 carton / 2.5 g in 1 packet45802-366-65—6 June 2019
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump45802-754-01—12 October 2018
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump69238-1013-2—10 April 2019
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump63629-8455-1—12 October 2018
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump71335-2742-1—29 July 2025
1 bottle, pump in 1 carton / 88 g in 1 bottle, pump72162-1426-2—5 December 2023
30 packet in 1 carton / 1.25 g in 1 packet16714-968-02—6 November 2019
30 packet in 1 carton / 2.5 g in 1 packet16714-969-02—6 November 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 12 October 1993Drugs@FDA
EU (EMA)WithdrawnEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenWithdrawnEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Testosterone 1.62% gel.

Compare 1

Other strengths and forms of Testosterone

Clinical summary

Testosterone is an androgen indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. It is available as gel, topical solution and implant pellets for transdermal and nasal use. MedsAcross supplies Testosterone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Testosterone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Testosterone 1.62% gel for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.